Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection.
about
Vaccines for Pseudomonas aeruginosa: a long and winding roadA novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models.The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem.Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency ImprovementIn vitro and in vivo properties of a fully human IgG1 monoclonal antibody that combats multidrug resistant Pseudomonas aeruginosa.Cloning, Expression, and Purification of Pseudomonas aeruginosa Flagellin, and Characterization of the Elicited Anti-Flagellin Antibody.Recent developments for Pseudomonas vaccines.Immunotherapy for infectious diseases in haematological immunocompromise.Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France.Filtration of crushed tablet suspensions has potential to reduce infection incidence in people who inject drugs.Liquid formulations for stabilizing IgMs during physical stress and long-term storage.Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.in Chronic Lung Infections: How to Adapt Within the Host?
P2860
Q26852817-2715AD9D-3D20-42AF-98C0-A9D9F65091C2Q30408273-DACB6D77-6491-4FEC-BD0A-C9A17B5DA30CQ34984415-8A5A7F16-FDAB-4ACD-A00D-52BA855AD8B0Q35513939-02AC9F98-AF5C-47C2-AB74-579552962B1DQ36029891-589BD494-D661-4E27-8D02-7374137D96B5Q36613653-72A3BC5D-5DAE-4072-8EB1-3A4D5A8F628AQ37216534-A0248DEA-18DA-4459-8AD8-1576E8B27F2BQ37937369-9892B600-5251-46DF-A068-4E0240961611Q39215653-D0B5AF1F-345A-46E5-B198-26566357A638Q40644061-0D9D9010-F69E-40DC-A3DB-8603CE2DBBFFQ41750205-F6714B15-F366-47CA-969D-0B62A6248F44Q44480024-B96CD51C-A16E-42AB-81BD-372696F22992Q51732617-667D2F43-DA69-4C27-8375-087D3A0D144BQ58580408-679CBDEC-9435-4AD0-8738-7203C9C0B113
P2860
Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Anti-Pseudomonas aeruginosa se ...... model of acute lung infection.
@en
Anti-Pseudomonas aeruginosa se ...... onoclonal antibody panobacumab
@nl
type
label
Anti-Pseudomonas aeruginosa se ...... model of acute lung infection.
@en
Anti-Pseudomonas aeruginosa se ...... onoclonal antibody panobacumab
@nl
prefLabel
Anti-Pseudomonas aeruginosa se ...... model of acute lung infection.
@en
Anti-Pseudomonas aeruginosa se ...... onoclonal antibody panobacumab
@nl
P2093
P2860
P356
P1476
Anti-Pseudomonas aeruginosa se ...... model of acute lung infection.
@en
P2093
P2860
P304
P356
10.1093/JAC/DKR038
P407
P577
2011-02-24T00:00:00Z